Digital Therapeutics to Register 27.7% CAGR to 2021, Expects M&M in Its Topical Research Report Now Available at MarketPublishers.com11 Aug 2016 • by Natalie Aster
LONDON – Globally, the digital therapeutics sector is likely to grow from USD 110 million in 2016 to reach a value of USD 457.9 million by 2021-end, registering a 27.7% CAGR over the projected period.
The rising incidence rate of chronic diseases, intense focus on preventive healthcare, technology developments, surging necessity of bringing health care costs under control, a great hike in VC investments, and the versatile advantages of digital therapeutics. Government incentives to support the development and uptake of digital therapeutics solutions also give a boost to this market’s growth.
Comparatively untapped markets in APAC’s developing countries and uninvestigated therapeutic applications have brought about a slew of opportunities for the digital therapeutics marketplace.
Meantime, a range of factors like a dearth of awareness and access to digital therapeutics programmes in developing regions, concerns about privacy of patients’ data, and resistance from conventional healthcare providers could limit the digital therapeutics sector’s growth.
Topical research report “Digital Therapeutics Market” elaborated by M&M draws up a detailed picture of the market on a global level, categorising it by type of application, sales channel, and by geographic region.
The study provides market size estimates for 2014, proceeding with forecasts of the market size and future trends through to 2021. It examines the various factors impacting the market, such as drivers, limiters, challenges, and opportunities. It gives a detailed industry analysis, covering regulatory requirements, Porter’s five forces analysis, pipeline products, VC investments, etc. The research report provides a competitive landscape evaluation, canvassing the trends and growth strategies of industry players over the past 3 years. Furthermore, detailed company profiles are included, comprising basic views on the dominant participants in the digital therapeutics universe and their product ranges, strategies, and developments.
More reports by our partner can be found at M&M page.